SAVE THE DATE FOR CANCER PROGRESS 2022!
Virtual on May 10-12, 2022

Save Your Virtual Seat for Cancer Progress 2022!

Since 1989, Cancer Progress is the only oncology conference that facilitates discussions of scientific progress within the context of development, regulatory, clinical, commercial and investment perspectives over three days of provocative, informative panel discussions. The conference will feature pivotal topics, frank discussions, vigorous debate, opportunities for audience questions and comments, and a partnering platform to enable meaningful connections and meetings with innovators, developers and investors.

Our 33rd Annual Meeting on May 10-12, 2022 will provide an unsurpassed learning experience for participants in quality of information, coverage of issues, and value of professional contacts. The quality of the speaking faculty is a major contributor to the popularity and value of this conference.

CLICK TO PRE-REGISTER

NEW IN ONCOLOGY!

Check out one of the newest episodes of Working in Oncology:
"Drug Development: How Do We Choose Which Unmet Needs Get Treated?" featuring Cello Health BioConsulting's EVP and Oncology Practice Head, Jeff Bockman (pictured).

Episode Description:
"Unmet need is a huge driver in the development of oncology treatments. But when it comes to choosing the therapies that “make the cut,” it’s not that simple. What are the risks involved? Where has efficacy been demonstrated in the treatment area and type? And the timeless question: who’s paying for it?"

arrow DOWNLOAD EPISODE

Cello Health is a global organization providing seamless consulting, insights, and communications, solutions to business challenges facing developers of pharmaceutical and biotechnology assets and brands.

Cello Health BioConsulting is a knowledge-based consultancy deeply rooted in science and the unique and ever-evolving challenges and opportunities facing the biopharma industry. Cello Health BioConsulting provides strategic advice for corporate growth and partnering strategies, disease area selection, indication prioritization, early market access strategy and early value profile development. Cello Health BioConsulting is known for “unconventional insight” – forward thinking, independent, objective and actionable strategic advice to realize value across all therapeutic areas and stages of development.

Cancer Progress by Cello Health
25-B Hanover Road, Suite 320
Florham Park, NJ 07932
Eileen Tuma, Conference Organizer
cellohealthbioconsulting.com | cancerprogressbycellohealth.com | cellohealth.com

linkedin twitter

Unsubscribe